Delivery Order SPE2DR25D2102-SPE2DR26FB2GL
- Not listed
- The Defense Logistics Agency awarded a $16,924.96 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with final delivery due by December 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, and the work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction under the company's existing contract vehicle with...
- The Defense Logistics Agency awarded a delivery order valued at $8,176.37 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency has awarded a $12,054.16 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on December 1, 2025, with an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a $36,275.25 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 9, 2025. This competitive award, issued on December 8, 2025, represents a firm fixed-price transaction with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a $3,267.57 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to...
- The Defense Logistics Agency awarded a $27,169.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed price, non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $6,948.71 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 5, 2025. This non-competitive, firm fixed-price delivery order was issued on November 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA's Medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,099.77 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 13, 2025, with completion scheduled for November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small single-transaction order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- The Defense Logistics Agency awarded a $11,589.48 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 4, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a contract ceiling value of $2,327.44 and an ultimate completion date of November 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- SPE2DR25D2102Indefinite Delivery Contract
- SPE2DR25D2102-SPE2DR26FB2GLDelivery Order
The Defense Logistics Agency awarded a $10,623.31 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Repatha is a PCSK9 inhibitor used for cardiovascular disease management, and this delivery order fulfills federal medical supply requirements within AmerisourceBergen's portfolio of specialty medications and brand-name pharmaceuticals supporting defense health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 11/30/25 |